GCGR and Hyperglycemia: Work characterizing the phenotype of Gcgr knockout mice (11, 12) and various therapeutic modalities targeting the glucagon-GCGR system to lower glucose in an array of preclinical rodent models (13–15) produced results that supported discovering agents to block glucagon action as a way to reduce hyperglycemia.